Case Review Form

      * Denotes required field.


      * First Name

      * Last Name

      * Email Address

      * Phone Number

      Cell Phone Number

      Office Phone Number

      Street Address




      Zip Code

      Please provide the best method and times to contact you:

      Date of birth of injured person

      Name of drug:

      Date you started taking the drug (mm-yyyy):

      Date you stopped taking the drug (mm-yyyy):

      Please describe any side effects:

      Other Info:

      No Yes, I agree to the Parker & Waichman LLP disclaimers.Click here to review all.

      Yes, I would like to receive the Parker & Waichman LLP monthly newsletter, InjuryAlert.

      please do not fill out the field below.

Florida Man Sues Makers of Type 2 Diabetes Drug Actos, Alleging It Caused His Bladder Cancer

Filed August 20th, 2013 Laurie

A lawsuit has been filed on behalf of a Florida man who alleges the Type 2 diabetes drug Actos caused him to develop bladder cancer. The suit was filed on July 15, 2013, in the U.S. District Court for the Western District of Louisiana by the national law firm Parker Waichman LLP. The case is one of thousands awaiting trial in a multidistrict litigation (MDL).

Takeda Pharmaceuticals, America; Takeda Pharmaceuticals USA, Inc. f/k/a Takeda Pharmaceuticals North America, Inc.; Takeda Pharmaceutical Company Limited; and Eli Lilly and Company have been named as Defendants. Jerrold S. Parker, founding partner of Parker Waichman LLP, serves on the Plaintiffs’ Steering Committee in the litigation.

According to the complaint, the Plaintiff alleges he took Actos from August 15, 2001, to November 23, 2009, which is when he was diagnosed with bladder cancer. On June 15, 2011, the U.S. Food and Drug Administration (FDA) warned that taking Actos for more than a year could significantly increase the risk of bladder cancer, and the agency changed the drug’s safety label to reflect this risk.

A study published in the British Medical Journal on May 31, 2012, showed that Actos users were twice as likely to develop bladder cancer after two years. And then, on July 3, 2012, the Canadian Medical Association Journal revealed that taking Actos increased patients’ risk of developing bladder cancer by 22 percent.

Be Sociable, Share!

Comments are closed.

Click Here Now, to Have an Attorney Answer Your
Medicinal Drug Injuries Questions
No Cost - No Obligation!